The partnership between Bespak and the MEU will align expert teams from the two organisations who will share knowledge and combine resources in order to fast-track time to clinic, and increase the throughput of low GWP pMDIs moving through clinical evaluation.

We recognise the immense value that Greater Manchester Blood Bikes bring to our community, and we remain committed to assisting them in any way we can.

“We are pleased to play our part as a clinical site in helping EP395 on its development journey towards helping future COPD patients.” – MEU CEO, David Rogers

Excellent to hear from Upstream Bio following MEU’s work with them as a one site solution to their clinical trial leads.

“Doctor Alex Mulvanny, the lead analytical scientist in MEU’s flow laboratory, proved a professional, reliable, engaged, and brilliant partner. Her input and support were vital to the success of our assay development and, eventually, to the application of this assay to the clinical participants enrolled at that clinical site.”

Cancer screening saves thousands of lives each year.

They can detect cancers at an early stage and in some cases, even prevent cancers from developing in the first place.

Manchester-based clinical research facility Medicines Evaluation Unit (MEU) is currently inviting members of the local community to take part in a free cancer screening programme.

We have recently paired with Arxx Therapeutics to help deliver their clinical trial. With the help of MEU and CRO Solutions, Arxx is happy to share that they have completed dosing of all healthy volunteers in their ongoing phase 1 study and successfully initiated the multiple ascending dose part in patients with psoriasis.

Professor Dave Singh, MEU Medical Director and Professor of Clinical Pharmacology and Respiratory Medicine, University of Manchester, presented at the European Respiratory Society (ERS) International Congress, Milan, earlier this week.

The ERS is an annual event that brings together the world’s respiratory experts to showcase the latest advances in respiratory medicine and science.

Professor Singh presented subjects including “Inhaled Corticosteroids in COPD: Who and When?” and “The Evolving Landscape in COPD and Implications for Disease Management”.

MEU Chairman and Professor of Respiratory Medicine, Ashley Woodcock, was interviewed on BBC Radio 4’s Today Show this morning about some good news concerning the environment.

Professor Woodcock spoke to Nick Robinson about how the ozone layer is on course to being repaired thanks to a decision to phase out CFCs (gases found in products such as aerosols, fridges and foam insulation) through the Montreal Protocol.

Professor Dave Singh, Medical Director of The Medicines Evaluation Unit (MEU), was interviewed by La Nación, a leading Argentine daily news publication about today’s challenges in asthma management.

Mi-Trial, a new company which has developed an innovative clinical trial companion system and app, has recently spun out from the University of Manchester with support from Elaros 24/7 Limited, Medicines Evaluation Unit Limited and the University of Manchester Innovation Factory.